胎儿超声检查实时人工智能诊断辅助系统的开发与临床验证
基于法国和英国两个转诊中心549例围产期表型数据,回顾性评估实时决策支持系统(DSS)在胎儿超声诊断中的性能。全表型输入时确诊诊断位于前10位列表的比例为93%,逐步输入为83%,全表型与逐步法的特异性分别为94%和96%,敏感性分别为99%和84%。
要点
- 全表型输入时93%的病例确诊诊断位于DSS前10位鉴别诊断列表中。
- 逐步输入时83%的病例确诊诊断位于前10位列表,平均需13次查询。
- 全表型法敏感性99%、特异性94%;逐步法敏感性84%、特异性96%。
核心结论
- DSS应用于真实世界数据时表现出高性能,该验证研究提示此类软件可改善围产期保健,为参与超声产前诊断的医护人员高效提供复杂且易被忽视的知识。
研究设计与样本
- 验证研究基于法国和英国两个转诊中心收集的549例围产期表型数据库,纳入标准为孕11周后胎儿超声可见至少一处异常且产后确认、相关罕见病经产后或死后检查(包括体格检查、基因检测和影像学)确认或排除、确诊综合征为DSS软件已知。
- 病例由软件回顾性评估,采用全表型单次输入或按软件提示逐步输入表型特征以模拟真实临床使用,不一致病例由外部专家小组裁决。
主要发现
- 数据集覆盖软件数据库中110/408(27%)的诊断,累积患病率为83%。
- 综合征病例中,经裁决后全表型输入的确诊诊断位于前10位列表的比例为93%,逐步输入为83%。
- 全表型法与逐步法的特异性分别为94%和96%,敏感性分别为99%和84%。
- 逐步法平均需要13次查询达到最终诊断集。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Prenatal diagnosis of a rare disease on ultrasound relies on a physician's ability to remember an intractable amount of knowledge. We developed a real-time decision support system (DSS) that suggests, at each step of the examination, the next phenotypic feature to assess, optimizing the diagnostic pathway to the smallest number of possible diagnoses. The objective of this study was to evaluate the performance of this real-time DSS using clinical data. METHODS: This validation study was conducted on a database of 549 perinatal phenotypes collected from two referral centers (one in France and one in the UK). Inclusion criteria were: at least one anomaly was visible on fetal ultrasound after 11 weeks' gestation; the anomaly was confirmed postnatally; an associated rare disease was confirmed or ruled out based on postnatal/postmortem investigation, including physical examination, genetic testing and imaging; and, when confirmed, the syndrome was known by the DSS software. The cases were assessed retrospectively by the software, using either the full phenotype as a single input, or a stepwise input of phenotypic features, as prompted by the software, mimicking its use in a real-life clinical setting. Adjudication of discordant cases, in which there was disagreement between the DSS output and the postnatally confirmed ('ascertained') diagnosis, was performed by a panel of external experts. The proportion of ascertained diagnoses within the software's top-10 differential diagnoses output was evaluated, as well as the sensitivity and specificity of the software to select correctly as its best guess a syndromic or isolated condition. RESULTS: The dataset covered 110/408 (27%) diagnoses within the software's database, yielding a cumulative prevalence of 83%. For syndromic cases, the ascertained diagnosis was within the top-10 list in 93% and 83% of cases using the full-phenotype and stepwise input, respectively, after adjudication. The full-phenotype and stepwise approaches were associated, respectively, with a specificity of 94% and 96% and a sensitivity of 99% and 84%. The stepwise approach required an average of 13 queries to reach the final set of diagnoses. CONCLUSIONS: The DSS showed high performance when applied to real-world data. This validation study suggests that such software can improve perinatal care, efficiently providing complex and otherwise overlooked knowledge to care-providers involved in ultrasound-based prenatal diagnosis. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Stirnemann JJ, Besson R, Spaggiari E, et al. Development and clinical validation of real-time artificial intelligence diagnostic companion for fetal ultrasound examination. Ultrasound Obstet Gynecol. 2023. PMID: 37161503. doi:10.1002/uog.26242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。